Theravance Biopharma Inc (TBPH)
Net Income Growth
-110.76%
Quarterly · Period ending:
TBPH Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-110.76%period ending
Latest reported-110.76%period ending
TBPH Quarterly Net Income YoY % (-26.03% → -110.76%)
Year-over-year change
High-resolution chart · PNG
TBPH net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -110.7559% | |
| 63.6718% | |
| 493.0186% | |
| 128.4691% | |
| 431.7503% | |
| -16.418% | |
| -82.4559% | |
| -41.8771% | |
| -5.6504% | |
| 47.193% | |
| 17.873% | |
| -100.9764% | |
| -91.0023% | |
| 14.8693% | |
| 67.6531% | |
| 2,696.1% | |
| 84.3698% | |
| 67.4368% | |
| 45.1792% | |
| 52.0552% | |
| 16.668% | |
| 4.0625% | |
| 10.9319% | |
| -26.0341% | |
| -57.8568% | |
| -14.4296% | |
| -30.7257% | |
| 1.6859% | |
| 2.4009% | |
| -11.5123% | |
| 42.2632% | |
| 11.1309% | |
| 38.4223% | |
| 0.3552% | |
| -29.0946% | |
| -96.9171% | |
| -40.3642% | |
| -54.968% | |
| -50.2075% | |
| 28.22% | |
| 0.7941% | |
| 0.7628% | |
| 30.297% | |
| 13.1774% | |
| 18.229% | |
| 29.2312% | |
| -45.8938% | |
| -32.6623% | |
| -49.4532% | |
| -86.5419% | |
| -51.052% | |
| -26.0255% |